Intravenous administration of selenium for intenstinal failure patients

Intravenous administration of selenium for intenstinal failure patients - Intravenous administration of selenium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035422

Enrollment

Registered

2019-01-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal failure patients

Interventions

We will administer selenium, which is 1~1.5 micro-g/kg/day, by intravenous everyday. We will check blood test 2 times per year.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients whose need parenteral nutrition for a long time.

Exclusion criteria

Exclusion criteria: The patients have allergy for selenium.

Design outcomes

Primary

Measure	Time frame
We will check blood test 2 times per year.	—

Countries

Japan

Contacts

Public ContactYuhki Arai

Niigata University Dental and Medical Hospital Pediatric Surgery

arai@med.niigata-u.ac.jp025-227-2258

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026